ArticleVaccines2025

Acceptance of Nirsevimab for the Prevention of Respiratory Syncytial Virus Infection in Neonates: A Cross-Sectional Survey in Emilia-Romagna, Italy.

Susanna Esposito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.